Collaboration between NanoVibronix and KevMed will allow many patients suffering from abdominal adhesions and pelvic pain syndromes, access to the PainShield to help alleviate their pain.
Online PR News – 16-October-2012 –NanoVibronix, Inc., a medical device company, which develops innovative therapeutic ultrasound products, has announced KevMed, LLC as its USA distributor for their innovative therapeutic ultrasound device, PainShield™. KevMed will distribute PainShield™ to the pelvic pain market.
"Our relationship with KevMed will allow us to reach many patients suffering from pain due to various pelvic pain syndromes and help them overcome their daily suffering and return to a more normal life," says Amir Rippel, VP Marketing at NanoVibronix. "Following our ongoing success in relieving the pain for patients with Trigeminal Neuralgia, an extremely painful neurological facial syndrome, we believe we can reduce the suffering and improve quality of life for many other patients with specific, but difficult to treat pain."
With over 25 years experience in the area of abdominal adhesions and pelvic pain syndromes, David Wiseman, Ph.D., President of KevMed, is excited to launch the PainShield to help these patients alleviate their pain. "In a clinical study, we found the PainShield ultrasound therapy to dramatically reduce pain in CAPPS (Complex Abdominal and Pelvic Pain Syndrome) patients, and an abstract with clinical data reflecting this positive finding was accepted for presentation at the upcoming International Pelvic Pain Society (IPPS) 2012 meeting in Chicago," says Wiseman. "I feel that for the first time we have a real chance to revolutionize the management of pain in these patients without the risks of surgery or drugs."
“We have a real chance to revolutionize the management of patients suffering from abdominal pain without the risks of surgery or drugs”
PainShield is the first hands-free, patch-based ultrasound device used to treat pain, thus allowing for an entirely new dimension in ultrasound treatment of pain and soft tissue healing. The PainShield consists of a disposable patch connected to a portable reusable driver and propagates therapeutic ultrasound waves to the desired area of the body. Patients can use PainShield in the clinical setting, at home, at work, and even while they sleep, dramatically improving access to treatment and patient compliance.
PainShield is cleared by the FDA for treatment of pain and carries the CE Mark.
The Chronic Pelvic Pain Market
Over 15 million patients are estimated to suffer one or more of several overlapping painful conditions that include pelvic pain, endometriosis, interstitial cystitis (IC), painful bladder syndrome, Irritable Bowel Syndrome (IBS), abdominal pain, vulvodynia, dyspareunia, adhesions, sacroiliac joint pain, pudendal neuralgia and pelvic floor dysfunction. Collectively, these conditions have been termed CAPPS (Complex Abdominal and Pelvic Pain Syndrome).
Located in Melville, New York, with a subsidiary in Nesher, Israel, NanoVibronix develops medical devices that utilize its proprietary and unique patch based therapeutic ultrasound technology. In addition to its PainShield product intended to treat pain, the company is expanding its portable, therapeutic platform to the WoundShield - targeting expedited healing of chronic and acute wounds. NanoVibronix has also developed and markets the UroShield catheter-based, disposable ultrasound, intended to reduce pain and discomfort and help prevent UTI in patients requiring indwelling urinary catheters.
Tel: +972-4-820 0581
KevMed, LLC was born from the work of the International Adhesions Society (IAS), which provides information, support, and advocacy to patients and their families suffering from Adhesion Related Disorder (ARD) and Complex Abdominal and Pelvic Pain Syndrome (CAPPS). The International Adhesions Society (IAS) was funded by Synechion, Inc., a research and consulting company specializing in the science and business of adhesions, and based on the expertise of its founder, Dr. David Wiseman. Research by the IAS has revealed new understandings of these conditions from the perspective of the patient and has resulted in the identification of PainShield as an effective treatment for pain in these conditions.
Dr. David Wiseman